HighTower Advisors’s Bristol-Myers Squibb BMY Stock Holding History

HighTower Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,600	Closed	-$2.88K	–	3694
2025 Q3	$2.88K	Buy	+2,600	New	+$121K	﹤0.01%	3743
2024 Q1	–	Sell	-200	Closed	-$341	–	3646
2023 Q4	$341	Buy	+200	New	+$10.5K	﹤0.01%	3587
2018 Q2	–	Sell	-68,200	Closed	-$375K	–	2252
2018 Q1	$375K	Buy	+68,200	New	+$4.39M	﹤0.01%	1564
2017 Q3	–	Sell	-83,000	Closed	-$108K	–	2242
2017 Q2	$108K	Buy	83,000 +28,600	+53%	+$1.56M	﹤0.01%	1951
2017 Q1	$104K	Buy	+54,400	New	+$2.98M	﹤0.01%	1867
2016 Q2	–	Sell	-300	Closed	-$555K	–	1791
2016 Q1	$555K	Buy	+300	New	+$18.9K	﹤0.01%	1328

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors's BMY Position: Q1 2026 in Review

HighTower Advisors increased its Bristol-Myers Squibb (BMY) stake by 2.5% in Q1 2026, buying an estimated $1.65M and bringing the position to 1,153,327 shares worth $69.9M. The position accounts for 0.07% of the portfolio, ranked #270.

HighTower Advisors first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $117M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

HighTower Advisors held 1,153,327 shares of Bristol-Myers Squibb worth $69.9M as of Q1 2026.
HighTower Advisors bought 28,288 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.65M.
Bristol-Myers Squibb made up 0.07% of HighTower Advisors's portfolio in Q1 2026, its #270 holding.
HighTower Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
HighTower Advisors's Bristol-Myers Squibb position peaked at $117M in Q2 2022.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.